Molecular Templates (MTEM) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Molecular Templates (NASDAQ:MTEM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$587,500.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$844,681.20 Get MTEM Insider Trade Alerts Want to know when executives and insiders are buying or selling Molecular Templates stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MTEM Insider Buying and Selling by Quarter Remove Ads Molecular Templates Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/14/2024Target N. V. BiotechMajor ShareholderSell1,279,820$0.66$844,681.20 4/2/2024Target N V BiotechMajor ShareholderBuy250,000$2.35$587,500.00 (Data available from 1/1/2013 forward) MTEM Insider Trading Activity - Frequently Asked Questions Who is on Molecular Templates's Insider Roster? The list of insiders at Molecular Templates includes Kevin M Lalande, Sean Mclennan, Shv Management Services, Llc, Target N V Biotech. Learn more on insiders at MTEM. What percentage of Molecular Templates stock is owned by insiders? 13.90% of Molecular Templates stock is owned by insiders. Learn more on MTEM's insider holdings. Which Molecular Templates insiders have been buying company stock? The following insider purchased MTEM shares in the last 24 months: Target N V Biotech ($2,587,493.35). How much insider buying is happening at Molecular Templates? Insiders have purchased a total of 533,687 MTEM shares in the last 24 months for a total of $2,587,493.35 bought. Which Molecular Templates insiders have been selling company stock? The following insider sold MTEM shares in the last 24 months: Target N. V. Biotech ($844,681.20). How much insider selling is happening at Molecular Templates? Insiders have sold a total of 1,279,820 Molecular Templates shares in the last 24 months for a total of $844,681.20 sold. Molecular Templates Key ExecutivesDr. Eric E. Poma Ph.D. (Age 52)CEO, Chief Scientific Officer & Director Compensation: $723.81kMs. Jason S Kim (Age 49)President, CFO, Treasurer & Principal Accounting Officer Compensation: $522.3kMs. Kristen Quigley B.A. (Age 53)Chief Operating Officer Dr. Grace KimChief Strategy Officer & Head of IRDr. Michelle Iwamoto-Fan J.D.Ph.D., Senior Vice President & General CounselDr. Joseph Phillips Ph.D.Senior VP & Head of CMC DevelopmentDr. Chris Moore Ph.D.Senior VP and Head of Preclinical Development & Translational Medicine More Insider Trading Tools from MarketBeat Related Companies Amgen Insider Ownership Gilead Sciences Insider Ownership Vertex Pharmaceuticals Insider Ownership Regeneron Pharmaceuticals Insider Ownership Alnylam Pharmaceuticals Insider Ownership Biogen Insider Ownership United Therapeutics Insider Ownership BioMarin Pharmaceutical Insider Ownership Incyte Insider Ownership Neurocrine Biosciences Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:MTEM) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Templates, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Templates With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.